Brief: FDA confirms that Cytotools can now request for clinical trial of DermaPro in US

bioXXmed AG

13/05/2015 13:20

May 13 (Reuters) - Cytotools AG  T5OG.DE : 
    * Successful dialogue with US food and drug administration 
(FDA) on the extension of the clinical testing program of 
DermaPro for the treatment of leg ulcers in the U.S. 
    * After reviewing existing preclinical and clinical data FDA 
confirms that now Cytotools can request for clinical trial of 
DermaPro in U.S. 
 
Source text for Eikon:  ID:nEQ2zgN7Na  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))